质和衰老:分子机制和治疗影响
Jingyan Hong1, Yaxin Liu1, Quan Peng1
1Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.
Aging and disease
|February 17, 2026
概括
衰老会损害铜的稳态,导致细胞死亡,称为cuproptosis. 这一过程加速了衰老,并加剧了与年龄相关的疾病,如阿尔茨海默氏症和帕金森病. 准铜平衡可能会提供新的治疗方法.
科学领域:
- 老年学是一门学科.
- 代谢学 代谢学 代谢学
- 细胞生物学 细胞生物学
背景情况:
- 全球人口老龄化增加了与年龄相关的疾病 (阿尔茨海默病,帕金森病,糖尿病等). ) 的情况.
- 衰老涉及生理衰退和代谢障碍,铜平衡不平衡是关键因素.
- 铜对酶至关重要,但衰老会破坏其调节,导致过载和cuproptosis.
研究的目的:
- 审查衰老和铜平衡之间的相互作用.
- 解释老龄化如何损害铜调节,以及这如何加速老龄化和相关疾病.
- 探索针对铜代谢和铜的治疗策略,以治疗与年龄有关的疾病.
主要方法:
- 文献综述,重点关注衰老,铜平衡和杯.
- 分析将铜不平衡与衰老过程联系起来的分子机制.
- 探索潜在的治疗干预措施.
主要成果:
- 衰老会影响铜吸收/流出平衡和细胞缓冲能力.
- 过多的铜会诱导cuproptosis,破坏线粒体功能和TCA循环.
- cuproptosis通过端粒磨损,氧化应激和炎症加速衰老.
结论:
- 不调节的铜恒温和铜是衰老和与年龄相关的疾病的核心.
- 针对铜平衡和铜的干预措施提供了治疗机会.
- 了解这些机制可以促进与年龄有关的疾病的治疗.
相关概念视频
Aging
874
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
874
The Effect of Aging on Tissues
3.8K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.8K
Mitochondria
20.8K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
20.8K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
730
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
730
Electron Transport Chain: Complex I and II
19.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
244
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
244


